AhR activation has been linked to the alleviation of colitis by reducing inflammatory cytokines like IL‐1β, IL‐6, and TNF‐α, while enhancing anti‐inflammatory cytokines, such as IL‐4, IL‐10, and IL‐22, and strengthening the intestinal epithelial barrier. The gene discussed is IL22; the disease is colitis.